Kevin Warsh Set to Be Sworn In as Federal Reserve Chair on Friday Analysts Warn MegaIPOs by SpaceX and OpenAI Could Signal Market Peak Amid Record Float Expectations UnitedHealth Group Gains Hedge Fund Interest as Dividend Stock with Mizuho Price Target Hike Lowes Warns of Shifting Consumer Sentiment Amid Housing Market Headwinds USChina Trade Tensions Persist as APEC Meetings Reveal Continued Disagreements UK Scorches on Hottest Day of 2026 as Bank Holiday Travel Disruptions Mount VRNS Q1 2026 Earnings Earnings Surprise Overshadows Missing Revenue Detail Clean Harbors Inc CLH Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Pagaya Technologies PGY Q1 2026 Earnings Massive EPS Surprise Masks Mixed Operational Signals BILI Q1 2026 Earnings EPS Surpasses Estimates by 135 Stock Gains NOV Q1 2026 Earnings EPS Misses Estimates Sharply as Revenue Details Remain Unreported DLTR Q1 2026 Earnings Small EPS Miss Amid Cautious Consumer Spending Brookfield Renewable Partners Edges Higher as Renewable Sector Shows Resilience Five Star Bancorp FSBC Consolidates Near Support as Banking Sector Faces Mixed Signals MetaVia Inc MTVA Sheds Over 8 as Shares Approach Key Support Launch Two Acquisition Corp LPBB Holds Steady Near 1066 Amid Low Volatility Analysis Nuveen Churchill Direct Lending Corp NCDL Edges Higher Remains in Consolidation Range Prediction Markets Signal Potential Fed Rate Hike by July 2027 CV Q1 2026 Earnings EPS Misses Estimates as Stock Declines Antalpha Platform Holding Faces Resistance After 22 Decline Immunome Inc IMNM Q1 2026 Earnings Narrower Loss Beats Estimates Stock Gains Modestly MED Q1 2026 Earnings EPS Surpasses Estimates Amid Cost Management Efforts WPP Q4 2025 Earnings EPS Beats Estimates Amid Digital and AIDriven Growth HWC Q1 2026 Earnings Modest EPS Beat Amid Stable Operating Environment BRX Q1 2026 Earnings Strong EPS Surprise of 635 Despite Slight Stock Decline TRIN Q1 2026 Earnings Small EPS Beat Amid Lack of Revenue Data Stock Edges Lower SPRY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment